Pharmafile Logo
Pharmafocus logo
Advanced Search

sackler

Showing 6 posts of 6 posts found.

920x920

Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows

December 17, 2019
Manufacturing and Production Oxy, OxyContin, Purdue Pharma, Sackler family, opioid, opioid crisis, sackler

An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 …

News
920x920

Sacklers file motion to throw lawsuit out of court

April 5, 2019
Medical Communications Massachusetts, OxyContin, Purdue Pharma, opioid crisis, opioids, sackler

Members of the Sackler family have asked a judge to throw a lawsuit – filed by Massachusetts attorney general Maura …

News

Sackler Trust halts donations in UK

March 26, 2019
Manufacturing and Production Sackler Trust, arts, culture, donations, funding, gallery, sackler

The Sackler Trust has announced it is suspending all new donations in the UK amid negative publicity linking the family’s …

News
920x920

Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019
Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …

News

Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech

October 10, 2018
Research and Development Mundipharma, biosimilar, cinfa biotech, sackler

In a bid to strengthen their biosimilar portfolio, the Cambridge based pain management company Mundipharma has acquired biosimilar development firm …

News

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024